Khalid Abd‐Elaziz

O1‐12‐05: PHASE 1 STUDY IN HEALTHY VOLUNTEERS OF THE O‐GLCNACASE INHIBITOR ASN120290 AS A NOVEL THERAPY FOR PROGRESSIVE SUPRANUCLEAR PALSY AND RELATED TAUOPATHIES

J. Michael Ryan, Anna Quattropani, Khalid Abd‐Elaziz et al. · Alzheimer s & Dementia · 2018 · 33 citations

Life Sciences, Neuroscience, Pharmacology +17

A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials

Khalid Abd‐Elaziz, Ingrid Duijkers, Lars Stöckl et al. · Human Reproduction · 2017 · 23 citations · Full text

Medicine, Endocrinology, Pharmacology +9

Oral follicle-stimulating hormone agonist tested in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function

Mireille Gerrits, Hester Kramer, Rachid El Galta et al. · Fertility and Sterility · 2016 · 12 citations · Full text

Medicine, Endocrinology, Reproductive Endocrinology +14

Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study

Valérie Bourdès, Peter Dogterom, André Alemán et al. · Neurology and Therapy · 2022 · 11 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first‐in‐human study

Lan Gao, Anuradha Bhattacharyya, Brian Beers et al. · British Journal of Clinical Pharmacology · 2024 · 11 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15